Ledger.Open graph →
SEC Form D · filed September 24, 2018

RespireRx Pharmaceuticals Inc

Offering
$1.5M
Sold
$251K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLEN ROCK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Donald R. Mclamb, Jr · Wilmington, DEExecPeter Mullen · New York, NYDirectorGlenn R. Hanson · Wilbraham, MAExec · DirectorSponsor Colony Hills Capital, LLC · Wilbraham, MADirectorLeath Bing · New York, NYExec · DirectorLuke J. Atwood · Richmond, VAExec · DirectorAmrit Shahzad · Beverly, MADirectorAndrew F. St Pierre · Burlington, MAExec · DirectorCharles Berg · New York, NYExec · DirectorChristine K. Funk · Sisters, ORExecMatt Harris · New York, NYDirectorClair C. Holley · Calgary, Alberta, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗